In utero pesticide exposure and childhood morbidity

Mandy Weselak1, Tye E Arbuckle, Donald T Wigle

  • 1R. Samuel McLaughlin Centre for Population Health Risk Assessment, Institute of Population Health, University of Ottawa, Canada. mweselak@ohri.ca

Environmental Research
|November 7, 2006
PubMed

Insights

Prenatal pesticide exposure may increase allergy risk in children. This study found suggestive links between pesticide exposure during pregnancy and allergies, particularly in male offspring, warranting further investigation.

Area of Science:

  • Environmental Health
  • Developmental Toxicology
  • Pediatric Epidemiology

Background:

  • Immune system development is a prolonged process from embryonic life through early postnatal stages.
  • Pesticide exposure during critical developmental windows may pose risks to immune function.
  • Limited human data exists on the long-term effects of in utero pesticide exposure on childhood health.

Purpose of the Study:

  • To investigate the association between pesticide exposure in pregnant farm couples and offspring health outcomes.
  • To examine the relationship between prenatal pesticide exposure and childhood conditions like persistent cough, bronchitis, asthma, allergies, and hayfever.

Main Methods:

  • Utilized data from the Ontario Farm Family Health Study.
  • Assessed pesticide exposure of farm couples during pregnancy.
  • Analyzed offspring health outcomes including respiratory illnesses and allergic conditions.

Main Results:

  • No significant associations were found between pesticide exposure during pregnancy and persistent cough, bronchitis, or asthma in offspring.
  • Suggestive evidence indicated a potential increase in allergies and hayfever in offspring, particularly males, exposed to certain pesticides prenatally.
  • Findings highlight potential sex-specific effects of prenatal pesticide exposure on immune-related outcomes.

Conclusions:

  • The study suggests a possible link between specific prenatal pesticide exposures and the development of allergies and hayfever in children.
  • Results are preliminary due to indirect exposure measures and limited existing human research, serving as a hypothesis for future studies.
  • Further research is needed to confirm these findings and elucidate the mechanisms of developmental immunotoxicity from pesticide exposure.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...